Publication number: 20250049714
Abstract: Provided herein are compounds, such as compounds of Formula (I), and pharmaceutically acceptable salts, hydrates, solvates, polymorphs, co-crystals, tautomers, stereoisomers, and isotopically labeled derivatives thereof, and compositions, methods, uses, and kits thereof. The compounds provided herein are lipids useful for delivery of polynucleotides, such as mRNA, for the treatment and/or prevention of various diseases and conditions (e.g., genetic disease, proliferative disease, hematological disease, neurological disease, liver disease, spleen disease, lung disease, painful condition, psychiatric disorder, musculoskeletal disease, a metabolic disorder, inflammatory disease, or autoimmune disease).
Type:
Application
Filed:
December 8, 2022
Publication date:
February 13, 2025
Applicant:
Massachusetts Institute of Technology
Inventors:
Daniel Griffith Anderson, Luke Hyunsik Rhym, Bowen Li, Akiva Gordon, Manan Rajith Singh, Jacob Witten